Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Multiplex Immunofluorescence for Human Pancreatic Ganglia v1

View through CrossRef
Purpose: This protocol is a multiplex immunofluorescence (MxIF) protocol adapted from t-CyCIF (dx.doi.org/10.17504/protocols.io.bjiukkew) and bleach & stain (Bady et al. 2023) protocols. Our protocol involves sequential incubations of primary antibodies using combinations of Opal reagents and fluorescence conjugated secondary antibodies for tyramine signal amplification (TSA) visualization following by standard immunofluorescence for primary antibodies not requiring TSA. Each cycle can consist of 4 or more primary antibodies depending on imaging equipment. Within and between staining cycles, antigen retrieval is performed to strip primary and secondary antibodies. Between staining cycles, a bleaching procedure is included to quench autofluorescence and deposited Opal TSA fluorescence. This protocol can be adapted to include a wide variety of primary antibodies with different combinations of Opal reagents and fluorescence conjugated secondary antibodies. Expected Outcome: By carefully selecting combinations of primary antibodies, secondary antibodies, and Opal reagents, one can visualize numerous markers in a single tissue section while avoiding cross-reactivity. As described by Bady et al., this allows for up to 15-20 antibodies to be applied to a single tissue section rather than the typical 4-7 antibodies that can be used in a single run. Scope: This protocol can serve as reference source for immunostaining human pancreas endocrine cells and intrinsic autonomic ganglia and is expected to also work well for formalin-fixed paraffin-embedded samples.
Title: Multiplex Immunofluorescence for Human Pancreatic Ganglia v1
Description:
Purpose: This protocol is a multiplex immunofluorescence (MxIF) protocol adapted from t-CyCIF (dx.
doi.
org/10.
17504/protocols.
io.
bjiukkew) and bleach & stain (Bady et al.
2023) protocols.
Our protocol involves sequential incubations of primary antibodies using combinations of Opal reagents and fluorescence conjugated secondary antibodies for tyramine signal amplification (TSA) visualization following by standard immunofluorescence for primary antibodies not requiring TSA.
Each cycle can consist of 4 or more primary antibodies depending on imaging equipment.
Within and between staining cycles, antigen retrieval is performed to strip primary and secondary antibodies.
Between staining cycles, a bleaching procedure is included to quench autofluorescence and deposited Opal TSA fluorescence.
This protocol can be adapted to include a wide variety of primary antibodies with different combinations of Opal reagents and fluorescence conjugated secondary antibodies.
Expected Outcome: By carefully selecting combinations of primary antibodies, secondary antibodies, and Opal reagents, one can visualize numerous markers in a single tissue section while avoiding cross-reactivity.
As described by Bady et al.
, this allows for up to 15-20 antibodies to be applied to a single tissue section rather than the typical 4-7 antibodies that can be used in a single run.
Scope: This protocol can serve as reference source for immunostaining human pancreas endocrine cells and intrinsic autonomic ganglia and is expected to also work well for formalin-fixed paraffin-embedded samples.

Related Results

Comparison of Three Molecular Methods for the Detection and Speciation of Five Human Plasmodium Species
Comparison of Three Molecular Methods for the Detection and Speciation of Five Human Plasmodium Species
In this study, three molecular assays (real-time multiplex polymerase chain reaction [PCR], merozoite surface antigen gene [MSP]-multiplex PCR, and the PlasmoNex Multiplex PCR Kit)...
A New Mathematical Model for EOR Displacements Honouring Oil Ganglia
A New Mathematical Model for EOR Displacements Honouring Oil Ganglia
Abstract During two-phase flow in porous media non-wetting phase is present simultaneously in states of mobile connected continuum and of trapped isolated ganglia...
Abstract IA-08: Clinical advances in pancreas adenocarcinoma
Abstract IA-08: Clinical advances in pancreas adenocarcinoma
Abstract Pancreatic adenocarcinoma (PDAC) remains one of the most lethal cancers today and is expected to be the second cause of cancer death in the coming decade. M...
The Dual Effects of Silibinin on Human Pancreatic Cells
The Dual Effects of Silibinin on Human Pancreatic Cells
Objective: Silibinin is a flavonoid with antihepatotoxic properties, and exhibits pleiotropic anticancer effects. However, the molecular mechanisms responsible for its anticancer a...
Activated Pancreatic Stellate Cells Enhance the Warburg Effect to Cause the Malignant Development in Chronic Pancreatitis
Activated Pancreatic Stellate Cells Enhance the Warburg Effect to Cause the Malignant Development in Chronic Pancreatitis
Abstract Background: Chronic pancreatitis (CP) is a precancerous condition associated with pancreatic ductal adenocarcinoma (PDAC), but its evolutionary mechanism is unclea...
Abstract 1603: Intra-pancreatic fat promotes the progression of PDAC by activating thermogenesis
Abstract 1603: Intra-pancreatic fat promotes the progression of PDAC by activating thermogenesis
Abstract Background: The presence of minimal intra-pancreatic fat deposition (IPFD) in the healthy human pancreas has been demonstrated in numerous studies. But exce...
Abstract 1695: Imaging of the interaction of pancreatic cancer and stellate cells during liver metastasis
Abstract 1695: Imaging of the interaction of pancreatic cancer and stellate cells during liver metastasis
Abstract Pancreatic stellate cells are involved in fibrosis of pancreatic cancer. An understanding of pancreatic cancer-cell interactions with stellate cells is crit...
High KLK7 Expression Predicts Unfavorable Outcomes in Patients with Resectable Pancreatic Ductal Adenocarcinoma
High KLK7 Expression Predicts Unfavorable Outcomes in Patients with Resectable Pancreatic Ductal Adenocarcinoma
Abstract Background Studies have shown that kallikrein-related peptidase 7 (KLK7) is abnormally expressed in a various of tumours and plays a crucial role in tumour progres...

Back to Top